Delivery Order SPE2DB22D2211-SPE2DB25FSDJU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,925.36 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Promethegan 25 mg suppositories (12-count units). The contract represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Promethegan 25 mg suppositories in quantities of 12 units. The order, valued at $2,577.42 with a firm fixed price structure, represents a non-set-aside competitive award. Performance will be executed from AmerisourceBergen Drug Corp's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,218.96 to AmerisourceBergen Drug Corp for the supply of Promethegan 12.5 mg suppositories (12-count packages). This firm fixed-price delivery order, issued on July 26, 2025, with completion targeted for July 28, 2025, represents a routine pharmaceutical procurement supporting federal medical supply requirements. The award was made through open competition with no set-aside designation, and performance will be executed at the...
- The Defense Logistics Agency awarded a $1,782.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Promethegan 25 mg suppositories (12-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under...
- The Defense Logistics Agency awarded a $7,329.92 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count packages) valued at $1,383.72 with a completion date of August 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,608.02 for Promethegan 25 mg suppositories (12-count units) with an ultimate completion date of July 7, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,746.59 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count units) with a completion date of July 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Promethegan 12.5 mg suppositories (12-count units) with a ceiling value of $1,950.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is executed under...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Promethegan 12.5 mg suppositories (quantity: 12 units) with a ceiling value of $1,950.24. This firm fixed-price delivery order, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation and was competitively awarded. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDJUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,031.58 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count) on August 21, 2025, with completion expected by August 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and running through December 2026. That prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The award reflects the vendor's established capability to meet federal pharmaceutical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/21/25 |